Back to Journals » Clinical Ophthalmology » Volume 12

A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease

Total article views   Abstract views HTML views PDF downloads Totals
6,757 Dovepress* 5,577 642+ 667 6,219
PubMed Central* 0 538 168 538
Totals 5,577 1,180 835 6,757
*Since 2 October 2018
+Since July 2016

View citations on PubMed Central and Google Scholar